EDITORIAL
Assessment of the potential of plasma fractionation processes to remove causative agents of transmissible spongiform encephalopathy
Characteristics of hepatitis C-positive blood donors in Victoria, Australia
Economic analysis of erythropoietin use in orthopaedic surgery
Nurse practitioner support for transfusion in patients with haematological disorders in hospital and at home
Collection of two peripheral blood stem cell concentrates from healthy donors
Evaluation of plasma and red cells obtained after leucocyte depletion of whole blood
Evaluation of an enzyme-linked immunosorbent assay kit (GTI PakPlus®) for the detection of antibodies against human platelet antigens
The murine monoclonal antibody NaM26-4C6 identifies a common structure on band 3 and glycophorin C
The case for standardization of transfusion medicine practices in French blood banks
The estimation of fetomaternal haemorrhage*
Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis
Addendum for guidelines for blood grouping and red cell antibody testing during pregnancy
STRUCTURAL BASIS FOR THE NON-SPECIFIC REACTIVITY OF HUMAN ANTIBODIES IN ELISA.
HIGHER AFFINITY MONOCLONAL ANTI-RH(D) PREPARED BY LIGHT CHAIN SHUFFLING AND SELECTED BY PHAGE DISPLAY.
THERAPEUTIC LEUKAPHERESIS FOR HYPERLEUKOCYTOSIS IN ACUTE MYELOGENOUS LEUKEMIA.
HYPOTENSIVE REACTIONS ASSOCIATED WITH PLATELET TRANSFUSION (PT) THROUGH LEUKOCYTE REDUCTION FILTERS (LRF): A REPORT OF 2 CASES.
DNA BASED DUFFY FYA/FYB GENOTYPING FOR Fy(a−b−) SICKLE CELL PATIENTS.
RECRUITING UNRELATED BONE MARROW DONORS BY USING AN ALTERNATIVE METHOD.
PREOPERATIVE AUTOLOGOUS BLOOD DONATIONS (PAD) IN WOMEN: ARE WE DOING MORE HARM THAN GOOD?
DIRECTED DONATION EXPERIENCE IN A PAEDIATRIC TERTIARY CARE HOSPITAL.
HHV-6 IN PATIENTS WHO ARE HETEROPHILE ANTIBODY NEGATIVE WITH ATYPICAL LYMPHOCYTES AND/OR LYMPHOCYTOSIS.
THE CANADIAN APHERESIS REGISTRY.
AUDIT OF CRYOPRECIPITATE USE IN A LARGE TEACHING HOSPITALS INAPPROPRIATE RATES REMAIN HIGH.
A CLINICAL CLASSIFICATION SCHEME AND AN AUDIT OF BLOOD UTILIZATION TO OPTIMIZE TRANSFUSION PRACTICE IN PATIENTS UNDERGOING SPINAL SURGERY.
ALLOGENEIC RED CELL TRANSFUSION IS AN INDEPENDENT RISK FACTOR FOR THE DEVELOPMENT OF POSTOPERATIVE BACTERIAL INFECTION.
SEROPREVALENCE OF TRYPANOSOMA CRUZI (T. CRUZI) IN CANADIAN BLOOD DONORS PRELIMINARY RESULTS.
PROFILE OF HIV POSITIVE BLOOD DONORS CONFIRMED BY WESTERN-BLOT TEST, MONTREAL CENTRE, CRC, 1994-1998.
EFFECTS OF DIFFERENT CONCENTRATIONS OF ANTICOAGULANT ON THE IN VITRO CHARACTERISTICS OF AUTOLOGOUS WHOLE BLOOD
A CASE STUDY OF TWO PARTIAL D PATIENTS
Data extraction and validation of blood donor records 1987-1996.
STRUCTURAL AND SEROLOGICAL PROPERTIES OF AMURINE ANTI-HUMAN IgG mAb PRODUCED IN TRANSGENIC ALFALFA PLANTS
REGULATION OF COAGULATION FACTOR X BY THE FIBRINOLYSIS PROTEASE PLASMIN
DIFFERENTIAL CATIONIC CHARGE RESTRICTION AND POLYREACTIVITY OF HUMAN IgM AND IgG ANTIBODIES REACTING WITH THE RHESUS(D) ANTIGEN.
ANTICOAGULANT ACTION OF HIRUDIN-ALBUMIN FUSION PROTEIN IN VIVO.
CD34+ CELLS DERIVED FROM BLOOD BUT NOT FROM BONE MARROW SECRETE GELATINASES/TYPE IV COLLAGENASES: THE STIMULATORY ROLE OF CYTOKINES.
ACCELERATED HIV REPLICATION BY VASOACTIVE INTESTINAL PEPTIDE RECEPTORS.
THE COST IMPACT AND USAGE PATTERN OF CLOTTING FACTORS FOR THE MANAGEMENT OF HEMOPHILIA A PATIENTS.
HOSPITAL USE OF RED CELL TRANSFUSION IN THE 1990'S - A SEVEN YEAR STUDY OF CHANGES IN PRACTICE
PREOPERATIVE AUTOLOGOUS DONATION IN CARDIAC SURGERY PATIENTS
IS THE PRESURGICAL BLEEDING TIME PREDICTIVE OF BLOOD LOSS IN CARDIOPULMONARY BYPASS SURGERY?
BLOOD TRANSFUSION UTILIZATION IN ELECTIVE TOTAL HIP REPLACEMENT (THR) SURGERY - THE POST-KREVER ERA.
PREOPERATIVE AUTOLOGOUS DONATION IN PAEDIATRIC PATIENTS - ASSESSMENT OF FERRITIN LEVELS AND RETICULOCYTE RESPONSES.
A DIRECTED DONATION (DD) PROGRAM REDUCES ALLOGENEIC BLOOD EXPOSURE IN NEONATAL INTENSIVE CARE.
DESCRIPTIVE EPIDEMIOLOGY OF BLOOD DONOR REPORTED RISK FACTORS.
THE SOLUBLE ACTIVE COMPONENT OF CD154 (CD40L) INHIBITS THE HUMAN ALLOIMMUNE RESPONSE IN HU-PBL-SCID MICE
EARLY DETECTION OF HYBRIDOMA CELL APOPTOSIS
A NOVEL C2 DOMAIN-CONTAINING PROTEIN, P110, IS BLOOD CELL SPECIFIC AND BINDS TO ANIONIC PHOSPHOLIPID.
ACTIN IS A CELL SURFACE COMPONENT ON ENDOTHELIAL AND BREAST CANCER CELLS
DEVELOPMENT OF AN ANIMAL MODEL TO ASSESS THE IMPACT OF THE ERYTHROCYTE STORAGE LESION ON TISSUE O2 AVAILABILITY FOLLOWING TRANSFUSION.
VARIATION IN WEIGHTS OF FRESH FROZEN PLASMA
RECIPIENT ADHERENT CELLS PRESENT DONOR PLATELET ANTIGENS TO ACTIVATE T CELLS AND STIMULATE ANTI-DONOR ANTIBODY PRODUCTION.
INTERACTION BETWEEN ANNEXIN II AND ANNEXIN V: IMPLICATIONS FOR CYTOMEGALOVIRUS
ANTIBODY MEDIATED SUPPRESSION OF THE HUMAN ALLOIMMUNE RESPONSE TO PLATELET TRANSFUSION IN HU-PBL-SCID MICE
EFFECT OF OVERLABELLING BEYOND THE BASE LABEL ON CELLULAR COMPONENTS SPECIFICATION.
ARE DUPLICATE SAMPLES REQUIRED FOR ABO CONFIRMATION FOR THE COMPUTER CROSSMATCH?
A NEW MULTICHANNEL VIRAL MARKER ANALYZER- A USER'S PERSPECTIVE
IMPACT OF CYROPRESERVATION ON THE ABSOLUTE VIABLE CD34+ CELL COUNT IN CORD BLOOD SAMPLES.
SECONDARY RESPONSE AFTER LIVER TRANSPLANTATION.
ANTI-FORMALDEHYDE ANTIBODY DETECTED IN PATHOLOGY LABORATORY WORKERS.
RH POSITIVE PATIENT WITH ANTI-G.
COMPARISON OF GEL AND TUBE TECHNIQUES FOR DIRECT ANTIGLOBULIN TESTS